Summary and Recommendations from the National Cancer Institute's Clinical Trials Planning Meeting on Novel Therapeutics for Non-Muscle Invasive Bladder Cancer.

Lerner SP, Bajorin DF, Dinney CP, Efstathiou JA, Groshen S, Hahn NM, Hansel D, Kwiatkowski D, O'Donnell M, Rosenberg J, Svatek R, Abrams JS, Al-Ahmadie H, Apolo AB, Bellmunt J, Callahan M, Cha EK, Drake C, Jarow J, Kamat A, Kim W, Knowles M, Mann B, Marchionni L, McConkey D, McShane L, Ramirez N, Sharabi A, Sharpe AH, Solit D, Tangen CM, Amiri AT, Van Allen E, West PJ, Witjes JA, Quale DZ

Open source

DOI
10.3233/blc-160053
Published
2016 Apr 27
Container
Bladder cancer (Amsterdam, Netherlands)
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3233/blc-160053,
  title = {Summary and Recommendations from the National Cancer Institute's Clinical Trials Planning Meeting on Novel Therapeutics for Non-Muscle Invasive Bladder Cancer.},
  author = {Lerner SP and Bajorin DF and Dinney CP and Efstathiou JA and Groshen S and Hahn NM and Hansel D and Kwiatkowski D and O'Donnell M and Rosenberg J and Svatek R and Abrams JS and Al-Ahmadie H and Apolo AB and Bellmunt J and Callahan M and Cha EK and Drake C and Jarow J and Kamat A and Kim W and Knowles M and Mann B and Marchionni L and McConkey D and McShane L and Ramirez N and Sharabi A and Sharpe AH and Solit D and Tangen CM and Amiri AT and Van Allen E and West PJ and Witjes JA and Quale DZ},
  year = {2016},
  journal = {Bladder cancer (Amsterdam, Netherlands)},
  doi = {10.3233/blc-160053},
  url = {https://doi.org/10.3233/blc-160053}
}

RIS

TY  - JOUR
TI  - Summary and Recommendations from the National Cancer Institute's Clinical Trials Planning Meeting on Novel Therapeutics for Non-Muscle Invasive Bladder Cancer.
AU  - Lerner SP
AU  - Bajorin DF
AU  - Dinney CP
AU  - Efstathiou JA
AU  - Groshen S
AU  - Hahn NM
AU  - Hansel D
AU  - Kwiatkowski D
AU  - O'Donnell M
AU  - Rosenberg J
AU  - Svatek R
AU  - Abrams JS
AU  - Al-Ahmadie H
AU  - Apolo AB
AU  - Bellmunt J
AU  - Callahan M
AU  - Cha EK
AU  - Drake C
AU  - Jarow J
AU  - Kamat A
AU  - Kim W
AU  - Knowles M
AU  - Mann B
AU  - Marchionni L
AU  - McConkey D
AU  - McShane L
AU  - Ramirez N
AU  - Sharabi A
AU  - Sharpe AH
AU  - Solit D
AU  - Tangen CM
AU  - Amiri AT
AU  - Van Allen E
AU  - West PJ
AU  - Witjes JA
AU  - Quale DZ
PY  - 2016
JO  - Bladder cancer (Amsterdam, Netherlands)
DO  - 10.3233/blc-160053
UR  - https://doi.org/10.3233/blc-160053
ER  - 

APA

SP, L., DF, B., CP, D., JA, E., S, G., NM, H., D, H., D, K., M, O., J, R., R, S., JS, A., H, A., AB, A., J, B., M, C., EK, C., C, D., J, J., A, K., W, K., M, K., B, M., L, M., D, M., L, M., N, R., A, S., AH, S., D, S., CM, T., AT, A., E, V. A., PJ, W., JA, W., & DZ, Q. (2016). Summary and Recommendations from the National Cancer Institute's Clinical Trials Planning Meeting on Novel Therapeutics for Non-Muscle Invasive Bladder Cancer.. Bladder cancer (Amsterdam, Netherlands). https://doi.org/10.3233/blc-160053

Source records